Mir-214-3p has a suppressive effect on CDK6 [53] and on MAPK1 [54], and its downregulation promotes cell-cycle progression, proliferation, migration, and invasion of ovarian cancer cells. The gene discussed is CDK6; the disease is ovarian carcinoma.